Reducing Harm from Respiratory Depression Associated with Opioids
The presentation will provide an overview of the latest published 2017 toolkit from the California Hospital Quality Institute (HQI), designed to assist healthcare organizations in their efforts to reduce harm from respiratory depression associated with opioid administration.
Successful completion of this course requires a score of 70% on the post-test.
Original webcast date: March 27, 2018
**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**
2023
Approved for 1.00 CRCE Hours.
SEMINAR OBJECTIVES
Provide an overview of the Hospital Quality Institute’s (HQI) toolkit
Describe the steps organizations may take to assess the current state of their respiratory depression prevention processes
Outline each phase of the respiratory monitoring care process and risk mitigation strategies described in the toolkit
Provide an overview of the current respiratory monitoring technologies available